Studies of germline genetic testing programs provide a snapshot of challenges at academic and community practices at the NSGC annual meeting.

Studies of germline genetic testing programs provide a snapshot of challenges at academic and community practices at the NSGC annual meeting.

In a paper published last year, Shumailov called this “model collapse,” a process by which an AI system becomes, in his words ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

Stifel 2025 Healthcare Conference November 13, 2025 10:00 AM ESTCompany ParticipantsJames Rogers - Chief Financial ...

This article explores how epigenetic mechanisms control gene expression, how their disruption drives cancer and how targeting these processes is reshaping cancer diagnosis and treatment.

Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a ...

Virus entry is thought to involve binding a unique receptor for cell attachment and cytosolic entry. For SARS-CoV-2 underlying the COVID-19 pandemic, angiotensin- converting enzyme 2 (ACE2) is widely ...

UBS Global Healthcare Conference 2025 November 10, 2025 5:00 PM ESTCompany ParticipantsBrandon Perthuis - Chief ...

Many human body odors waft from under our arms and from our groins. That’s where apocrine glands are concentrated, producing ...

This study provides valuable insights into the role of the NF-kB and IKK signaling pathways in γδ T cell development and survival, using robust genetic mouse models. While the research is ...